This paper examines the identification of specific nucleic acid and protein expression profiles associated with bladder cancer. With over 50,000 new cases diagnosed annually in the United States, bladder cancer represents a significant morbidity risk, particularly in older demographics. The study highlights the role of mRNA expression in tumor diagnosis, specifically targeting the identification of unique algorithms (such as the 209-gene algorithm) to improve upon traditional diagnostic methods. Proposed Outline
Comparison of expression profiles in malignant vs. benign tissue. Prognostic indicators based on genetic signatures. 54415.rar
Description of specific gene sequences involved in bladder tumor development. This paper examines the identification of specific nucleic
Epidemiology of bladder cancer in the U.S. (incidence and mortality). Limitations of current diagnosis (cystoscopy, cytology). The need for molecular biomarkers. Description of specific gene sequences involved in bladder
on the "209 gen alg" mentioned in the Professional Rates_APR2022 dataset. Professional Rates_APR2022
Identification of nucleic acid and protein expression profiles (mRNA signatures).
Methods for identifying therapeutic agents targeting these specific mRNA profiles.